


Alaxia joins EU consortium to combat drug-resistant lung infections

Vygon Group acquires Pilot, specialist in ECG central venous catheter tip location and navigation devices

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Traxens shortlisted for 2019 Trophées Or Normes organized by members of the French Standardization Association AFNOR

Medicen Paris Region reorganizes its Strategic Areas of Activities (DAS) to bring engineers and doctors closer together

News report – Innovative Solutions Providers’ symposium

Horus Pharma signe des partenariats avec Eyeneed et Ophtabase

Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia
